U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722507) titled 'Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis' on July 20.
Brief Summary: This study will explore how adults in Japan with pulmonary fibrosis decide whether to continue or discontinue antifibrotic therapy after experiencing antifibrotic therapy-related adverse events.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Progressive Pulmonary Fibrosis
Intervention:
DRUG: Antifibrotic therapy
As per product label prescribed by treating physician
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services ...